Teclistamab-cqyv (Tecvayli) led to clinically meaningful responses in patients with heavily pretreated multiple myeloma who ...

Peter M. Voorhees, MD, shares key insights from the 2025 American Society of Clinical Oncology Annual Meeting, specifically in the multiple myeloma space.

Ichnos Glenmark Innovation & AbbVie ink exclusive global licensing agreement for ISB 2001: New York Saturday, July 12, 2025, 12:00 Hrs [IST] IGI Therapeutics SA, a wholly owned su ...

A nasal ‘molecular shield’ developed by researchers may soon block mugwort pollen, offering relief from one of the most ...

Blood donation is an act of selflessness. People who donate blood regularly can help save lives and provide hope for cancer ...

The longtime music director of the Windsor Symphony Orchestra says his recent battle with a recurrence of non-Hodgkin ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...